The Gerontological Society of America

  • Online Store
  • Site Map
  • Press Room
  • Decrease font size
  • Default font size
  • Increase font size
  • RSS Feed

Member Log-in

Forgot your username?

Password is case sensitive
Forgot your password?

Not a Member?   Join Now!

Home About Us NIH Geroscience Summit
Advances in Geroscience: Impact on Healthspan and Chronic Disease


Date and Location

Wednesday, October 30 – Thursday, October 31, 2013
The Natcher Conference Center (Building 45 located on the National Institutes of Health campus)
Bethesda, Maryland

A scientific conference in which 50 renowned scientists will discuss the extent to which the physiological effects of aging represent a common major risk factor for most chronic diseases affecting the aging population.

Download the 2013 Program Booklet.


Videocasts from each day are available online:

Follow the event on Twitter with @geronsociety, @alzheimers_NIH, and @aging_research.
The hashtag is #agingsummit. Also visit Facebook to view photos from the event.


In addition to a plenary session launched by Francis S. Collins, MD, PhD, director of the National Institutes of Health (NIH), there were seven scientific sessions on inflammation, adaptation to stress, epigenetics and regulatory RNA, metabolism, macromolecular damage, proteostasis, and stem cells and regeneration. The Summit program was developed by the Trans-NIH GeroScience Interest Group (GSIG) at the NIH, a recently  formed group focused on the relationships between aging and age-related disease and disability. The GSIG is among the largest trans-NIH interest groups.

The National Institute on Aging has posted a video featuring Felipe Sierra, PhD, director of the Division of Aging Biology, discussing the GSIG and the summit.

Summit Objectives
  • To use the foundational concepts of geroscience to understand basic cellular and molecular underpinnings of aging as a principal risk factor for a variety of chronic diseases
  • To explore common mechanisms governing relationships between aging and chronic diseases
  • To identify new pathways for research collaboration